Skip to content

Home
About
Services
Insights
Contact
Français

Rethinking the Reimbursement Review of Orphan Medicines in Canada

/ Publication / By webadmin

Gerry Jeffcott, Provincial Reimbursement Advisor, February 2019

Post navigation

← Previous Post

Search for:

Recent Posts

PHARMAFOCUS 2028
THE CANADIAN DRUG AGENCY: THE FEDERAL GOVERNMENT’S NATIONAL PHARMACARE AGENDA GIVES CADTH A NEW NAME AND AN EXPANDED MANDATE
PROFILES IN REIMBURSEMENT – CONTRIBUTIONS MADE BY THE BRITISH COLUMBIA PHARMACEUTICAL, LABORATORY AND BLOOD SERVICES DIVISION (BC PLBSD)
CANADIANS NEED ACCESS TO MEDICINES – AFTER THAT, THERE’S LITTLE AGREEMENT ON PHARMACARE PLANS
THE CASE OF THE MISSING FEDERAL MONEY

Recent Comments

Archives

Categories

Publication

Meta

Log in
Entries feed
Comments feed
WordPress.org

3Sixty Public Affairs is Canada’s leader in health sector-focused policy, public affairs and advocacy

Suite 604 – 150 Metcalfe Street,
Ottawa, Ontario, K2P 1P1
343 961-9715

info@3sixtypublicaffairs.com

Home
About
Services
Insights
Contact

© 2024 3SIXTY PUBLIC AFFAIRS INC. ALL RIGHTS RESERVED.